when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Endocrinology & Metabolism · news · pharmadog

← back to Endocrinology & Metabolism

News · Endocrinology & Metabolism

226 stories

Jul 15, 26STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expectstat

Jul 14, 26STAT+: Anthropic’s Claude Science is coming for Kendall Squarestat

Jul 14, 26STAT+: Akero team, backed by Fairmount, launches new immunology companystat

Jul 14, 26STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study showsstat

Jul 14, 2612 ideas for tackling the U.S. alcohol epidemicstat

Jul 14, 26STAT+: Drug metabolism AI competition results show that bigger may not always be betterstat

Jul 9, 26Opinion: Who benefits from classifying obesity as a disease?stat

Jul 8, 26Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study saysstat

Jul 8, 26Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsstat

Jul 7, 26Kailera says obesity pill succeeds in late-stage trial in Chinabiopharma dive

Jul 7, 26STAT+: Compass says depression drug has long-lasting benefitsstat

Jul 7, 26Vertex to acquire Crinetics in $10B foray into endocrine disease drugsbiopharma dive

Jul 7, 26STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and morestat

Jul 6, 26STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A boomsstat

Jul 6, 26New CDER appointment elevates longtime GLP-1 reviewerendpoints

Jul 6, 26Opinion: The smart way to regulate the peptide boomstat

Jul 1, 26Statins and blood pressure drugs changing health risks of obesity, study suggestsstat

Jul 1, 26STAT+: The biotech scorecard for the third quarter: 15 stock-moving events to watchstat

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 26, 26Alkermes’ incoming CEO has a plan to outplay Lilly and Takedabiopharma dive

Jun 16, 26Opinion: I’m an Alzheimer’s specialist. I still missed it in my own fatherstat

Jun 10, 26Diabetes association leader apologizes for expulsion of members, pledges to rebuild truststat

Jun 9, 26Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cutsstat

Jun 8, 26When it’s time to save a limb, novel clinic meets unhoused people where they arestat

Jun 8, 26Opinion: American horses are obese, toostat

Jun 7, 26STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADAstat

Jun 6, 26STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet endingstat

Jun 5, 26STAT+: Newer GLP-1s, pushback on research cuts, and a proteststat

Jun 5, 26Senior NIH official pushes MAHA strategy to skeptical ADA audiencestat

Jun 4, 26Male puberty is understudied — but when it starts may predict long-term health risksstat

← prevpage 4 of 8next →